HL
Haylex Laboratories Inc.
SEC filingBiotechnology · Kerrville, TX
Amount raised$50Ksold at filing
Total offering$1.5M$1.5M still open
Investors in the raise1count reported to the SEC
FiledApr 21, 2026first sale Apr 15, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Mark Stephen MaloneExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.